Jan Basile to Adrenergic beta-Antagonists
This is a "connection" page, showing publications Jan Basile has written about Adrenergic beta-Antagonists.
Connection Strength
1.421
-
One size does not fit all: the role of vasodilating beta-blockers in controlling hypertension as a means of reducing cardiovascular and stroke risk. Am J Med. 2010 Jul; 123(7 Suppl 1):S9-15.
Score: 0.346
-
Beta-blockers for treatment of hypertension. Postgrad Med. 2003 Dec; 114(6 Suppl Role):11-7.
Score: 0.219
-
Beta-blockers for preventing sudden cardiac death. Postgrad Med. 2003 Dec; 114(6 Suppl Role):30-4.
Score: 0.219
-
Titration of beta-blockers in heart failure. How to maximize benefit while minimizing adverse events. Postgrad Med. 2003 Mar; 113(3):63-70; quiz 3.
Score: 0.208
-
Halting the progression of heart failure: finding the optimal combination therapy. Cleve Clin J Med. 2002 Feb; 69(2):104-5, 109-10, 112.
Score: 0.193
-
The role of nitric oxide in improving endothelial function and cardiovascular health: focus on nebivolol. Am J Med. 2010 Jul; 123(7 Suppl 1):S2-8.
Score: 0.087
-
Management of global risk across the continuum of hypertensive heart disease. J Clin Hypertens (Greenwich). 2006 Aug; 8(8 Suppl 2):21-30; quiz 39-40.
Score: 0.066
-
Cardioprotection: the role of beta-blocker therapy. J Clin Hypertens (Greenwich). 2005 Jul; 7(7):409-16.
Score: 0.061
-
Combination therapy in hypertension. J Am Soc Hypertens. 2010 Jan-Feb; 4(1):42-50.
Score: 0.021